PMP22 and Charcot-Marie-Tooth disease type 1A: In summary, we have demonstrated that IFB-088 treatment improved the neuropathy in MpzR98C/ + mice, a CMT1B mouse model, and in C3-PMP22 mice, a CMT1A mouse model.